<DOC>
	<DOCNO>NCT01059513</DOCNO>
	<brief_summary>This observational study questionnaire use obtain quality life data patient undergo hypo-fractionated course stereotactic body radiotherapy ( SBRT ) treatment prostate cancer . The SBRT consider standard care patient , official component study .</brief_summary>
	<brief_title>Hypo-fractionated Stereotactic Body Radiotherapy Localized Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Eligible patient clinical stage T1c , T2a , T2b , prebiopsy PSA level &lt; 10 ng/mL biopsy Gleason score 3+3 ( 3+4 few 30 % biopsy core involve ) . The ability understand willingness sign write informed consent necessary . Patients tumor parameter fall outside inclusion criterion . Patients evidence imagining ( bone scan , CT , MRI ) suggestive disseminate disease . Patients form prior prostate treatment ( surgery , radiotherapy , cryotherapy , high intensity focus ultrasound , TURP ) . A prior course hormone therapy ( androgen deprivation ) great 3 month duration . The use concurrent investigational agent . There exclusion due comorbid disease illnesses except patient severe inflammatory bowel disease . No life expectancy restriction apply . Performance status consider .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>T1c</keyword>
	<keyword>T2a</keyword>
	<keyword>T2b</keyword>
</DOC>